Duloxetine hydrochloride structure
Duloxetine hydrochloride
In addition, duloxetine recipients experienced
significantly greater increases in their average voiding interval than placebo
recipients (15.0–20.4 versus 1.7–8.5 minutes). The most commonly observed adverse
events associated with duloxetine therapy are nausea, dry mouth, constipation,
decreased appetite, fatigue, somnolence, and increased sweating. As with other
5-HT reuptake inhibitors, duloxetine is contraindicated in patients taking MAO
inhibitors. Additionally, it is contraindicated
Find 87 Related Holders
JIANGSU HANSOH PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
European Union
European Union
API Registration Country
API Inactive
QILU PHARMACEUTICAL CO., LTD.
European Union
European Union
API Registration Country
API Inactive
CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
Union Quimico Farmaceutica S.A.
European Union
European Union
API Registration Country
API Inactive
ZHEJIANG HISOAR PHARMACEUTICAL CO LTD CHUANNAN BRANCH
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Duloxetine hydrochloride
-
Dingwang Technology (Wuhan) Co., Ltd.
CN1 YR
Contact Supplier -
ROYAL PHARM
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Shanghai Wonder Pharmaceutical Co.,Ltd
CN1 YR
Contact Supplier -
Chiyan
CN1 YR
Contact Supplier